These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 15902631)

  • 1. [The "EVA" Trial: Evaluation of the Efficacy of Diagnostic Methods (Mammography, Ultrasound, MRI) in the secondary and tertiary prevention of familial breast cancer. Preliminary results after the first half of the study period].
    Kuhl CK; Schrading S; Weigel S; Nüssle-Kügele K; Sittek H; Arand B; Morakkabati N; Leutner C; Tombach B; Nordhoff D; Perlet C; Rieber A; Heindel W; Brambs HJ; Schild H
    Rofo; 2005 Jun; 177(6):818-27. PubMed ID: 15902631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
    Kuhl C; Weigel S; Schrading S; Arand B; Bieling H; König R; Tombach B; Leutner C; Rieber-Brambs A; Nordhoff D; Heindel W; Reiser M; Schild HH
    J Clin Oncol; 2010 Mar; 28(9):1450-7. PubMed ID: 20177029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk.
    Podo F; Sardanelli F; Canese R; D'Agnolo G; Natali PG; Crecco M; Grandinetti ML; Musumeci R; Trecate G; Bergonzi S; De Simone T; Costa C; Pasini B; Manuokian S; Spatti GB; Vergnaghi D; Morassut S; Boiocchi M; Dolcetti R; Viel A; De Giacomi C; Veronesi A; Coran F; Silingardi V; Turchett D; Cortesi L; De Santis M; Federico M; Romagnoli R; Ferrari S; Bevilacqua G; Bartolozzi C; Caligo MA; Cilotti A; Marini C; Cirillo S; Marra V; Martincich L; Contegiacomo A; Pensabene M; Capuano I; Burgazzi GB; Petrillo A; Bonomo L; Carriero A; Mariani-Costantini R; Battista P; Cama A; Palca G; Di Maggio C; D'Andrea E; Bazzocchi M; Francescutti GE; Zuiani C; Londero V; Zunnui I; Gustavino C; Centurioni MG; Iozzelli A; Panizza P; Del Maschio A
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):115-24. PubMed ID: 12585665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer.
    Riedl CC; Ponhold L; Flöry D; Weber M; Kroiss R; Wagner T; Fuchsjäger M; Helbich TH
    Clin Cancer Res; 2007 Oct; 13(20):6144-52. PubMed ID: 17947480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
    Kuhl CK; Schrading S; Leutner CC; Morakkabati-Spitz N; Wardelmann E; Fimmers R; Kuhn W; Schild HH
    J Clin Oncol; 2005 Nov; 23(33):8469-76. PubMed ID: 16293877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced MR imaging of breast lesions and effect on treatment.
    Schelfout K; Van Goethem M; Kersschot E; Colpaert C; Schelfhout AM; Leyman P; Verslegers I; Biltjes I; Van Den Haute J; Gillardin JP; Tjalma W; Van Der Auwera JC; Buytaert P; De Schepper A
    Eur J Surg Oncol; 2004 Jun; 30(5):501-7. PubMed ID: 15135477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene).
    Kuhl CK
    J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):103-6. PubMed ID: 12585663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition.
    Kriege M; Brekelmans CT; Boetes C; Muller SH; Zonderland HM; Obdeijn IM; Manoliu RA; Kok T; Rutgers EJ; de Koning HJ; Klijn JG;
    Cancer; 2006 Jun; 106(11):2318-26. PubMed ID: 16615112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of MRI screening for breast cancer in high-risk patients with LCIS and atypical hyperplasia.
    Port ER; Park A; Borgen PI; Morris E; Montgomery LL
    Ann Surg Oncol; 2007 Mar; 14(3):1051-7. PubMed ID: 17206485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.
    Lehman CD; Blume JD; Weatherall P; Thickman D; Hylton N; Warner E; Pisano E; Schnitt SJ; Gatsonis C; Schnall M; DeAngelis GA; Stomper P; Rosen EL; O'Loughlin M; Harms S; Bluemke DA;
    Cancer; 2005 May; 103(9):1898-905. PubMed ID: 15800894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary role of adjunctive breast magnetic resonance imaging and scintimammography in patients of all ages undergoing breast cancer surgery.
    Howarth D; Slater S; Lau P; Booker J; Clark D; Sillar R
    Australas Radiol; 2005 Aug; 49(4):289-97. PubMed ID: 16026435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of magnetic resonance imaging in screening women at high risk of breast cancer.
    Warner E
    Top Magn Reson Imaging; 2008 Jun; 19(3):163-9. PubMed ID: 18941396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition.
    Essink-Bot ML; Rijnsburger AJ; van Dooren S; de Koning HJ; Seynaeve C
    Breast; 2006 Oct; 15(5):673-6. PubMed ID: 16556497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.
    Kuhl CK; Schmutzler RK; Leutner CC; Kempe A; Wardelmann E; Hocke A; Maringa M; Pfeifer U; Krebs D; Schild HH
    Radiology; 2000 Apr; 215(1):267-79. PubMed ID: 10751498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of dynamic magnetic resonance imaging in the evaluation of tumor response to preoperative concurrent radiochemotherapy for large breast cancers: a prospective phase II study.
    Bollet MA; Thibault F; Bouillon K; Meunier M; Sigal-Zafrani B; Savignoni A; Diéras V; Nos C; Salmon R; Fourquet A;
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):13-8. PubMed ID: 17449193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for hereditary breast cancer.
    Dent R; Warner E
    Semin Oncol; 2007 Oct; 34(5):392-400. PubMed ID: 17920893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in DCIS detection rates by MRI over time in a high-risk breast screening study.
    Warner E; Causer PA; Wong JW; Wright FC; Jong RA; Hill KA; Messner SJ; Yaffe MJ; Narod SA; Plewes DB
    Breast J; 2011; 17(1):9-17. PubMed ID: 21251121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation.
    Al-Hallaq HA; Mell LK; Bradley JA; Chen LF; Ali AN; Weichselbaum RR; Newstead GM; Chmura SJ
    Cancer; 2008 Nov; 113(9):2408-14. PubMed ID: 18823018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.